BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
255 results:

  • 1. A1CF Binding to the p65 Interaction Site on NKRF Decreased IFN-β Expression and p65 Phosphorylation (Ser536) in Renal Carcinoma Cells.
    Liu Y; Yang J; Weng D; Xie Y
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612387
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SIRT5 promote malignant advancement of chordoma by regulating the desuccinylation of c-myc.
    Jiang M; Huang Z; Chen L; Deng T; Liu J; Wu Y
    BMC Cancer; 2024 Mar; 24(1):386. PubMed ID: 38532359
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Prevalence and Radiologic Features of Renal Cancers Associated with
    Charbel C; Causa Andrieu PI; Soliman M; Woo S; Zheng J; Capanu M; Nikolovski I; Vargas HA; Abusamra M; Carlo MI
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230063. PubMed ID: 38456787
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway.
    Huang B; Ren J; Ma Q; Yang F; Pan X; Zhang Y; Liu Y; Wang C; Zhang D; Wei L; Ran L; Zhao H; Liang C; Wang X; Wang S; Li H; Ning H; Ran A; Li W; Wang Y; Xiao B
    Mol Cancer; 2024 Feb; 23(1):34. PubMed ID: 38360682
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
    Wu Y; Chen W; Miao H; Xu T
    BMC Cancer; 2024 Feb; 24(1):210. PubMed ID: 38360598
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Actual encounters of the kidney kind: Exploring 48 cases of renal collision tumors through the lens of literature.
    Lerma LA; Pease G; Malleis J; Antic T; Hes O; Tretiakova M
    Hum Pathol; 2024 Mar; 145():26-33. PubMed ID: 38340966
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer.
    Wang JY; Gross M; Urban RR; Jorge S
    Curr Treat Options Oncol; 2024 Mar; 25(3):313-329. PubMed ID: 38270801
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Succinate dehydrogenase deficient renal cell carcinoma: A case report of an uncommon renal cancer.
    Kodare D; Menon S; Prakash G; Desai S
    Indian J Cancer; 2023 Oct; 60(4):583-585. PubMed ID: 38189645
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
    Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
    JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis.
    Yoodee S; Peerapen P; Plumworasawat S; Malaitad T; Thongboonkerd V
    J Transl Med; 2023 Nov; 21(1):862. PubMed ID: 38017409
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
    Rogala J; Zhou M
    Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. S100A16 cooperates with DEPDC1 to promote the progression and angiogenesis of nephroblastoma through PI3K/Akt/mTOR pathway.
    Geng G; Xu Y; Li Q; Li Q; Yuan L; Dong M; Ming M
    Pol J Pathol; 2023; 74(3):182-193. PubMed ID: 37955537
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD
    Chen Y; Lu Y; Yang L; Ma W; Dong Y; Zhou S; Liu N; Gan W; Li D
    J Exp Clin Cancer Res; 2023 Sep; 42(1):252. PubMed ID: 37770905
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Jin B
    Cancer Med; 2023 Oct; 12(19):19889-19903. PubMed ID: 37747077
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumab + axitinib vs. ipilimumab + nivolumab.
    Shah NJ; Sura SD; Shinde R; Shi J; Singhal P; Perini RF; Motzer RJ
    Urol Oncol; 2023 Nov; 41(11):459.e1-459.e8. PubMed ID: 37722984
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Protective Effect of Platelet-Rich Plasma on Cisplatin-Induced Nephrotoxicity in Adult Male Albino Rats: Histological and Immunohistochemical Study.
    Kelada MN; Elagawany A; El Sekily NM; El Mallah M; Abou Nazel MW
    Biol Trace Elem Res; 2024 Mar; 202(3):1067-1083. PubMed ID: 37420147
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Succinate Dehydrogenase Defects Giant Renal Cell Carcinoma.
    Sun X; Wang G; Huang Z; Li P; Yang B; Wang T; Li J
    Urol Int; 2023; 107(8):819-822. PubMed ID: 37393904
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability.
    Yang F; Ma Q; Huang B; Wang X; Pan X; Yu T; Ran L; Jiang S; Li H; Chen Y; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Li W; Xiao B
    J Transl Med; 2023 Jun; 21(1):402. PubMed ID: 37340423
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. TROAP Promotes the Proliferation, Migration, and Metastasis of kidney Renal Clear Cell Carcinoma with the Help of STAT3.
    Wang J; Wan H; Mi Y; Wu S; Li J; Zhu L
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298609
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. L-carnitine Modulates Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights to Oxidative Stress, Inflammation, Synaptic Plasticity, Liver/brain, and kidney/brain Axes.
    Morid OF; Menze ET; Tadros MG; George MY
    J Neuroimmune Pharmacol; 2023 Sep; 18(3):310-326. PubMed ID: 37140732
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.